Cancer Immunotherapy Market Size, Share & Trends Report

Cancer Immunotherapy Market Size, Share & Trends Analysis Report, By Product, By Application, By Distribution (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By End Use, By Region, And Segment Forecasts, 2024 - 2030

Report ID: GVR-1-68038-693-6
Number of Pages: 110
Format: Electronic (PDF)

Historical Range: 2018 - 2022
Industry: Healthcare

Market Segmentation

Cancer Immunotherapy Product Outlook (Revenue, USD Million, 2018 - 2030)
- Monoclonal Antibodies
- Immunomodulators
- Oncolytic Viral Therapies and Cancer Vaccines
Cancer Immunotherapy Application Outlook (Revenue, USD Million, 2018 - 2030)
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Head and Neck Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Others
Cancer Immunotherapy Distribution Outlook (Revenue, USD Million, 2018 - 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Cancer Immunotherapy End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals & Clinics
- Cancer Research Centers
- Others
Cancer Immunotherapy Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Cancer Immunotherapy Market, by Product
    - Monoclonal Antibodies
    - Immunomodulators
    - Oncolytic Viral Therapies and Cancer Vaccines
  - North America Cancer Immunotherapy Market, by Application
    - Lung Cancer
    - Breast Cancer
    - Colorectal Cancer
    - Melanoma
    - Prostate Cancer
    - Head and Neck Cancer
    - Ovarian Cancer
    - Pancreatic Cancer
    - Others
  - North America Cancer Immunotherapy Market, by Distribution
    - Hospital Pharmacy
    - Retail Pharmacy
    - Online Pharmacy
  - North America Cancer Immunotherapy Market, by End Use
    - Hospitals & Clinics
    - Cancer Research Centers
    - Others
  - U.S.
    - U.S. Cancer Immunotherapy Market, by Product
      - Monoclonal Antibodies
      - Immunomodulators
      - Oncolytic Viral Therapies and Cancer Vaccines
    - U.S. Cancer Immunotherapy Market, by Application
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Melanoma
      - Prostate Cancer
      - Head and Neck Cancer
      - Ovarian Cancer
      - Pancreatic Cancer
      - Others
    - U.S. Cancer Immunotherapy Market, by Distribution
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - U.S. Cancer Immunotherapy Market, by End Use
      - Hospitals & Clinics
      - Cancer Research Centers
      - Others
  - Canada
    - Canada Cancer Immunotherapy Market, by Product
      - Monoclonal Antibodies
      - Immunomodulators
      - Oncolytic Viral Therapies and Cancer Vaccines
    - Canada Cancer Immunotherapy Market, by Application
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Melanoma
      - Prostate Cancer
      - Head and Neck Cancer
      - Ovarian Cancer
      - Pancreatic Cancer
      - Others
    - Canada Cancer Immunotherapy Market, by Distribution
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - Canada Cancer Immunotherapy Market, by End Use
      - Hospitals & Clinics
      - Cancer Research Centers
      - Others
- Europe
  - Europe Cancer Immunotherapy Market, by Product
    - Monoclonal Antibodies
    - Immunomodulators
    - Oncolytic Viral Therapies and Cancer Vaccines
  - Europe Cancer Immunotherapy Market, by Application
    - Lung Cancer
    - Breast Cancer
    - Colorectal Cancer
    - Melanoma
    - Prostate Cancer
    - Head and Neck Cancer
    - Ovarian Cancer
    - Pancreatic Cancer
    - Others
  - Europe Cancer Immunotherapy Market, by Distribution
    - Hospital Pharmacy
    - Retail Pharmacy
    - Online Pharmacy
  - Europe Cancer Immunotherapy Market, by End Use
    - Hospitals & Clinics
    - Cancer Research Centers
    - Others
  - Germany
    - Germany Cancer Immunotherapy Market, by Product
      - Monoclonal Antibodies
      - Immunomodulators
      - Oncolytic Viral Therapies and Cancer Vaccines
    - Germany Cancer Immunotherapy Market, by Application
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Melanoma
      - Prostate Cancer
      - Head and Neck Cancer
      - Ovarian Cancer
      - Pancreatic Cancer
      - Others
    - Germany Cancer Immunotherapy Market, by Distribution
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - Germany Cancer Immunotherapy Market, by End Use
      - Hospitals & Clinics
      - Cancer Research Centers
      - Others
  - UK
    - UK Cancer Immunotherapy Market, by Product
      - Monoclonal Antibodies
      - Immunomodulators
      - Oncolytic Viral Therapies and Cancer Vaccines
    - UK Cancer Immunotherapy Market, by Application
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Melanoma
      - Prostate Cancer
      - Head and Neck Cancer
      - Ovarian Cancer
      - Pancreatic Cancer
      - Others
    - UK Cancer Immunotherapy Market, by Distribution
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - UK Cancer Immunotherapy Market, by End Use
      - Hospitals & Clinics
      - Cancer Research Centers
      - Others
  - France
    - France Cancer Immunotherapy Market, by Product
      - Monoclonal Antibodies
      - Immunomodulators
      - Oncolytic Viral Therapies and Cancer Vaccines
    - France Cancer Immunotherapy Market, by Application
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Melanoma
      - Prostate Cancer
      - Head and Neck Cancer
      - Ovarian Cancer
      - Pancreatic Cancer
      - Others
    - France Cancer Immunotherapy Market, by Distribution
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - France Cancer Immunotherapy Market, by End Use
      - Hospitals & Clinics
      - Cancer Research Centers
      - Others
  - Italy
    - Italy Cancer Immunotherapy Market, by Product
      - Monoclonal Antibodies
      - Immunomodulators
      - Oncolytic Viral Therapies and Cancer Vaccines
    - Italy Cancer Immunotherapy Market, by Application
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Melanoma
      - Prostate Cancer
      - Head and Neck Cancer
      - Ovarian Cancer
      - Pancreatic Cancer
      - Others
    - Italy Cancer Immunotherapy Market, by Distribution
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - Italy Cancer Immunotherapy Market, by End Use
      - Hospitals & Clinics
      - Cancer Research Centers
      - Others
  - Spain
    - Spain Cancer Immunotherapy Market, by Product
      - Monoclonal Antibodies
      - Immunomodulators
      - Oncolytic Viral Therapies and Cancer Vaccines
    - Spain Cancer Immunotherapy Market, by Application
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Melanoma
      - Prostate Cancer
      - Head and Neck Cancer
      - Ovarian Cancer
      - Pancreatic Cancer
      - Others
    - Spain Cancer Immunotherapy Market, by Distribution
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - Spain Cancer Immunotherapy Market, by End Use
      - Hospitals & Clinics
      - Cancer Research Centers
      - Others
  - Denmark
    - Denmark Cancer Immunotherapy Market, by Product
      - Monoclonal Antibodies
      - Immunomodulators
      - Oncolytic Viral Therapies and Cancer Vaccines
    - Denmark Cancer Immunotherapy Market, by Application
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Melanoma
      - Prostate Cancer
      - Head and Neck Cancer
      - Ovarian Cancer
      - Pancreatic Cancer
      - Others
    - Denmark Cancer Immunotherapy Market, by Distribution
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - Denmark Cancer Immunotherapy Market, by End Use
      - Hospitals & Clinics
      - Cancer Research Centers
      - Others
  - Sweden
    - Sweden Cancer Immunotherapy Market, by Product
      - Monoclonal Antibodies
      - Immunomodulators
      - Oncolytic Viral Therapies and Cancer Vaccines
    - Sweden Cancer Immunotherapy Market, by Application
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Melanoma
      - Prostate Cancer
      - Head and Neck Cancer
      - Ovarian Cancer
      - Pancreatic Cancer
      - Others
    - Sweden Cancer Immunotherapy Market, by Distribution
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - Sweden Cancer Immunotherapy Market, by End Use
      - Hospitals & Clinics
      - Cancer Research Centers
      - Others
  - Norway
    - Norway Cancer Immunotherapy Market, by Product
      - Monoclonal Antibodies
      - Immunomodulators
      - Oncolytic Viral Therapies and Cancer Vaccines
    - Norway Cancer Immunotherapy Market, by Application
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Melanoma
      - Prostate Cancer
      - Head and Neck Cancer
      - Ovarian Cancer
      - Pancreatic Cancer
      - Others
    - Norway Cancer Immunotherapy Market, by Distribution
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - Norway Cancer Immunotherapy Market, by End Use
      - Hospitals & Clinics
      - Cancer Research Centers
      - Others
- Asia Pacific
  - Asia Pacific Cancer Immunotherapy Market, by Product
    - Monoclonal Antibodies
    - Immunomodulators
    - Oncolytic Viral Therapies and Cancer Vaccines
  - Asia Pacific Cancer Immunotherapy Market, by Application
    - Lung Cancer
    - Breast Cancer
    - Colorectal Cancer
    - Melanoma
    - Prostate Cancer
    - Head and Neck Cancer
    - Ovarian Cancer
    - Pancreatic Cancer
    - Others
  - Asia Pacific Cancer Immunotherapy Market, by Distribution
    - Hospital Pharmacy
    - Retail Pharmacy
    - Online Pharmacy
  - Asia Pacific Cancer Immunotherapy Market, by End Use
    - Hospitals & Clinics
    - Cancer Research Centers
    - Others
  - China
    - China Cancer Immunotherapy Market, by Product
      - Monoclonal Antibodies
      - Immunomodulators
      - Oncolytic Viral Therapies and Cancer Vaccines
    - China Cancer Immunotherapy Market, by Application
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Melanoma
      - Prostate Cancer
      - Head and Neck Cancer
      - Ovarian Cancer
      - Pancreatic Cancer
      - Others
    - China Cancer Immunotherapy Market, by Distribution
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - China Cancer Immunotherapy Market, by End Use
      - Hospitals & Clinics
      - Cancer Research Centers
      - Others
  - Japan
    - Japan Cancer Immunotherapy Market, by Product
      - Monoclonal Antibodies
      - Immunomodulators
      - Oncolytic Viral Therapies and Cancer Vaccines
    - Japan Cancer Immunotherapy Market, by Application
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Melanoma
      - Prostate Cancer
      - Head and Neck Cancer
      - Ovarian Cancer
      - Pancreatic Cancer
      - Others
    - Japan Cancer Immunotherapy Market, by Distribution
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - Japan Cancer Immunotherapy Market, by End Use
      - Hospitals & Clinics
      - Cancer Research Centers
      - Others
  - India
    - India Cancer Immunotherapy Market, by Product
      - Monoclonal Antibodies
      - Immunomodulators
      - Oncolytic Viral Therapies and Cancer Vaccines
    - India Cancer Immunotherapy Market, by Application
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Melanoma
      - Prostate Cancer
      - Head and Neck Cancer
      - Ovarian Cancer
      - Pancreatic Cancer
      - Others
    - India Cancer Immunotherapy Market, by Distribution
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - India Cancer Immunotherapy Market, by End Use
      - Hospitals & Clinics
      - Cancer Research Centers
      - Others
  - Thailand
    - Thailand Cancer Immunotherapy Market, by Product
      - Monoclonal Antibodies
      - Immunomodulators
      - Oncolytic Viral Therapies and Cancer Vaccines
    - Thailand Cancer Immunotherapy Market, by Application
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Melanoma
      - Prostate Cancer
      - Head and Neck Cancer
      - Ovarian Cancer
      - Pancreatic Cancer
      - Others
    - Thailand Cancer Immunotherapy Market, by Distribution
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - Thailand Cancer Immunotherapy Market, by End Use
      - Hospitals & Clinics
      - Cancer Research Centers
      - Others
  - South Korea
    - South Korea Cancer Immunotherapy Market, by Product
      - Monoclonal Antibodies
      - Immunomodulators
      - Oncolytic Viral Therapies and Cancer Vaccines
    - South Korea Cancer Immunotherapy Market, by Application
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Melanoma
      - Prostate Cancer
      - Head and Neck Cancer
      - Ovarian Cancer
      - Pancreatic Cancer
      - Others
    - South Korea Cancer Immunotherapy Market, by Distribution
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - South Korea Cancer Immunotherapy Market, by End Use
      - Hospitals & Clinics
      - Cancer Research Centers
      - Others
  - Australia
    - Australia Cancer Immunotherapy Market, by Product
      - Monoclonal Antibodies
      - Immunomodulators
      - Oncolytic Viral Therapies and Cancer Vaccines
    - Australia Cancer Immunotherapy Market, by Application
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Melanoma
      - Prostate Cancer
      - Head and Neck Cancer
      - Ovarian Cancer
      - Pancreatic Cancer
      - Others
    - Australia Cancer Immunotherapy Market, by Distribution
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - Australia Cancer Immunotherapy Market, by End Use
      - Hospitals & Clinics
      - Cancer Research Centers
      - Others
- Latin America
  - Latin America Cancer Immunotherapy Market, by Product
    - Monoclonal Antibodies
    - Immunomodulators
    - Oncolytic Viral Therapies and Cancer Vaccines
  - Latin America Cancer Immunotherapy Market, by Application
    - Lung Cancer
    - Breast Cancer
    - Colorectal Cancer
    - Melanoma
    - Prostate Cancer
    - Head and Neck Cancer
    - Ovarian Cancer
    - Pancreatic Cancer
    - Others
  - Latin America Cancer Immunotherapy Market, by Distribution
    - Hospital Pharmacy
    - Retail Pharmacy
    - Online Pharmacy
  - Latin America Cancer Immunotherapy Market, by End Use
    - Hospitals & Clinics
    - Cancer Research Centers
    - Others
  - Brazil
    - Brazil Cancer Immunotherapy Market, by Product
      - Monoclonal Antibodies
      - Immunomodulators
      - Oncolytic Viral Therapies and Cancer Vaccines
    - Brazil Cancer Immunotherapy Market, by Application
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Melanoma
      - Prostate Cancer
      - Head and Neck Cancer
      - Ovarian Cancer
      - Pancreatic Cancer
      - Others
    - Brazil Cancer Immunotherapy Market, by Distribution
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - Brazil Cancer Immunotherapy Market, by End Use
      - Hospitals & Clinics
      - Cancer Research Centers
      - Others
  - Mexico
    - Mexico Cancer Immunotherapy Market, by Product
      - Monoclonal Antibodies
      - Immunomodulators
      - Oncolytic Viral Therapies and Cancer Vaccines
    - Mexico Cancer Immunotherapy Market, by Application
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Melanoma
      - Prostate Cancer
      - Head and Neck Cancer
      - Ovarian Cancer
      - Pancreatic Cancer
      - Others
    - Mexico Cancer Immunotherapy Market, by Distribution
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - Mexico Cancer Immunotherapy Market, by End Use
      - Hospitals & Clinics
      - Cancer Research Centers
      - Others
  - Argentina
    - Argentina Cancer Immunotherapy Market, by Product
      - Monoclonal Antibodies
      - Immunomodulators
      - Oncolytic Viral Therapies and Cancer Vaccines
    - Argentina Cancer Immunotherapy Market, by Application
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Melanoma
      - Prostate Cancer
      - Head and Neck Cancer
      - Ovarian Cancer
      - Pancreatic Cancer
      - Others
    - Argentina Cancer Immunotherapy Market, by Distribution
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - Argentina Cancer Immunotherapy Market, by End Use
      - Hospitals & Clinics
      - Cancer Research Centers
      - Others
- Middle East and Africa
  - Middle East and Africa Cancer Immunotherapy Market, by Product
    - Monoclonal Antibodies
    - Immunomodulators
    - Oncolytic Viral Therapies and Cancer Vaccines
  - Middle East and Africa Cancer Immunotherapy Market, by Application
    - Lung Cancer
    - Breast Cancer
    - Colorectal Cancer
    - Melanoma
    - Prostate Cancer
    - Head and Neck Cancer
    - Ovarian Cancer
    - Pancreatic Cancer
    - Others
  - Middle East and Africa Cancer Immunotherapy Market, by Distribution
    - Hospital Pharmacy
    - Retail Pharmacy
    - Online Pharmacy
  - Middle East and Africa Cancer Immunotherapy Market, by End Use
    - Hospitals & Clinics
    - Cancer Research Centers
    - Others
  - South Africa
    - South Africa Cancer Immunotherapy Market, by Product
      - Monoclonal Antibodies
      - Immunomodulators
      - Oncolytic Viral Therapies and Cancer Vaccines
    - South Africa Cancer Immunotherapy Market, by Application
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Melanoma
      - Prostate Cancer
      - Head and Neck Cancer
      - Ovarian Cancer
      - Pancreatic Cancer
      - Others
    - South Africa Cancer Immunotherapy Market, by Distribution
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - South Africa Cancer Immunotherapy Market, by End Use
      - Hospitals & Clinics
      - Cancer Research Centers
      - Others
  - Saudi Arabia
    - Saudi Arabia Cancer Immunotherapy Market, by Product
      - Monoclonal Antibodies
      - Immunomodulators
      - Oncolytic Viral Therapies and Cancer Vaccines
    - Saudi Arabia Cancer Immunotherapy Market, by Application
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Melanoma
      - Prostate Cancer
      - Head and Neck Cancer
      - Ovarian Cancer
      - Pancreatic Cancer
      - Others
    - Saudi Arabia Cancer Immunotherapy Market, by Distribution
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - Saudi Arabia Cancer Immunotherapy Market, by End Use
      - Hospitals & Clinics
      - Cancer Research Centers
      - Others
  - UAE
    - UAE Cancer Immunotherapy Market, by Product
      - Monoclonal Antibodies
      - Immunomodulators
      - Oncolytic Viral Therapies and Cancer Vaccines
    - UAE Cancer Immunotherapy Market, by Application
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Melanoma
      - Prostate Cancer
      - Head and Neck Cancer
      - Ovarian Cancer
      - Pancreatic Cancer
      - Others
    - UAE Cancer Immunotherapy Market, by Distribution
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - UAE End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Cancer Research Centers
      - Others
  - Kuwait
    - Kuwait Cancer Immunotherapy Market, by Product
      - Monoclonal Antibodies
      - Immunomodulators
      - Oncolytic Viral Therapies and Cancer Vaccines
    - Kuwait Cancer Immunotherapy Market, by Application
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Melanoma
      - Prostate Cancer
      - Head and Neck Cancer
      - Ovarian Cancer
      - Pancreatic Cancer
      - Others
    - Kuwait Cancer Immunotherapy Market, by Distribution
      - Hospital Pharmacy
      - Retail Pharmacy
      - Online Pharmacy
    - Kuwait Cancer Immunotherapy Market, by End Use
      - Hospitals & Clinics
      - Cancer Research Centers
      - Others

Cancer Immunotherapy Market Dynamics

Drivers: Introduction Of Newer Drugs

The cancer immunotherapy market remains a dynamic space with the emergence of novel and improved therapeutics intended to target the disease at molecular & genetic levels, while bettering the disease management & treatment rates as well as lowering the global disease burden. Checkpoint inhibitors, such as Opdivo and Keytruda, continue to dominate the global market-driven by label expansions, wider market penetration, and increased consumer awareness. As the cancer immunotherapy market continues to grow with increase in the number of branded drugs and their generic counterparts, new entrants are required to offer more than what the currently marketed medicines claim. Improved safety & efficacy profile, tolerance, minimization of adverse effects, mechanism of action, and route of delivery are some of the key parameters considered for the new drugs. Current research in immunotherapy is focused on the following areas: combating drug resistance, predicting patient response to immunotherapy, and deeper understanding of immunosuppression & cancer cell evasion. Furthermore, a robust development pipeline is one of the major driving factors for strong growth of the cancer immunotherapy market. Immuno-oncology agents have shown promising results with improved survival rate and lower toxicity. Combination therapies target multiple pathways within the tumor microenvironment that can potentially increase the effectiveness of immunotherapy. Companies are increasingly focusing on development of targeted therapies as novel regimens for cancer treatment. Gene therapy is emerging as one of the most innovative treatment approaches and has the potential to be used as a promising cancer treatment.

Driver: Technological Advancements

Development of immune checkpoint inhibitors for cancer treatment signifies one of the most successful approaches in cancer drug discovery. However, single-agent activity of PD-1/ PD-L1 molecules, such as Opdivo and Keytruda, for certain cancer, such as ovarian cancer, is only 10%- 15%. The National Cancer Institute (NCI) has funded multiple combination therapies for studies in cancer types to enhance the activity of checkpoint inhibitors. Targeted molecules are generally less toxic as compared to traditional chemotherapeutic drugs. In April 2019, the FDA approved the combination of Keytruda and Inlyta for the treatment of advanced renal cancer. The recent approvals of immuno-therapeutics will contribute significantly to the market growth. Disease prognosis for patients not eligible for surgical resection remains poor despite novel targeted therapies entering the market. Unmet need for treatments providing complete remissions and long-lasting response exists in the market, which presents a strong commercial opportunity to launch breakthrough first-in-class therapies.

Restraint: Adverse Effects Of Currently Marketed Therapies

Currently available therapies are associated with several adverse effects, such as pain, insomnia, fatigue, nausea, and gastrointestinal conditions. These adverse effects impact the overall quality of life of patients. In addition, management of these adverse effects incurs extra cost. However, the number and intensity of adverse effects are likely to decline with introduction of novel drugs, as they are approved after assessment of associated adverse effects. In addition, prolonged consumption of immunotherapeutic drugs may cause severe damage to the organs and increase the incidence of organ failure cases.

What Does This Report Include?

This section will provide insights into the contents included in this cancer immunotherapy market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Cancer immunotherapy market qualitative analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Cancer immunotherapy market quantitative analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.